» Articles » PMID: 16647955

Reduced Expression of Claudin-7 Correlates with Invasion and Metastasis in Squamous Cell Carcinoma of the Esophagus

Overview
Journal Hum Pathol
Specialty Pathology
Date 2006 May 2
PMID 16647955
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Claudins are transmembrane proteins that seal tight junctions, bind with peripheral protein zonula occludens (ZO)-1, and are known to play an important role in several normal tissues and cancers. However, the role of claudin-1 and claudin-7 expressions in esophageal squamous cell carcinoma remains to be clarified. In the present study, we confirmed the expressions of claudin-1, claudin-7, and ZO-1 in the prickle cell layer of the normal human esophageal squamous epithelium. The expressions of claudin-1 and claudin-7 at the invasive front of the esophageal squamous cell carcinoma were analyzed immunohistochemically to clarify their role in tumor progression. Reduced expression of claudin-7 at the invasive front of the esophageal cancer was significantly associated with the depth of invasion (P = .004), stage (P = .038), lymphatic vessel invasion (P = .001), and lymph node metastasis (P = .014). In contrast, significant association was not detected between claudin-1 expression and clinicopathologic factors except for histologic differentiation of the tumor (P = .0029). Comparison of claudin-7 expression at the invasive front of the primary tumor and its corresponding metastatic lymph nodes revealed significant reduction in claudin-7 expression in the metastatic lymph nodes (P = .007). These results suggest that the reduced expression of claudin-7 at the invasive front of esophageal squamous cell carcinoma may lead to tumor progression and subsequent metastatic events. Thus, claudin-7 can be a novel marker for the prediction of lymph node metastasis.

Citing Articles

CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway.

Yang L, Wang X, Lin Q, Shen G, Chen H J Mol Histol. 2024; 55(6):1259-1270.

PMID: 39438406 PMC: 11567981. DOI: 10.1007/s10735-024-10267-5.


Claudins in Cancer: A Current and Future Therapeutic Target.

Hana C, Thaw Dar N, Galo Venegas M, Vulfovich M Int J Mol Sci. 2024; 25(9).

PMID: 38731853 PMC: 11083183. DOI: 10.3390/ijms25094634.


Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.

Romanowicz A, Lukaszewicz-Zajac M, Mroczko B Int J Mol Sci. 2024; 25(8).

PMID: 38673838 PMC: 11050399. DOI: 10.3390/ijms25084253.


Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?.

Lukaszewicz-Zajac M, Mroczko B Cancers (Basel). 2024; 16(1).

PMID: 38201579 PMC: 10778544. DOI: 10.3390/cancers16010152.


Tight Junction Protein Signaling and Cancer Biology.

Nehme Z, Roehlen N, Dhawan P, Baumert T Cells. 2023; 12(2).

PMID: 36672179 PMC: 9857217. DOI: 10.3390/cells12020243.